IP Library Granted Patent US 7,202,052
Granted Patent B2
US 7,202,052 · App. 10/850,060 · Granted Apr 10, 2007

Mitogenic oxygenase regulators

Assignee: Emory University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,202,052
App. No.
10/850,060
Granted
Apr 10, 2007
Kind
B2
Abstract

The present invention relates to new genes encoding for the production of novel nox enzyme proteins involved in generation of reactive oxygen intermediates that affect cell division. The present invention also provides vectors containing these genes, cells transfected with these vectors, antibodies raised against these novel proteins, kits for detection, localization and measurement of these genes and proteins, and methods to determine the activity of drugs to affect the activity of the proteins of the present invention.

Claims (11)

1. An isolated protein, wherein the isolated protein comprises the amino acid sequence of SEQ ID NO:4, a fragment of SEQ ID NO:4 capable of superoxide production or a substitution of SEQ ID NO:4 of less than 1% of the amino acid sequence, wherein the isolated protein is capable of superoxide production.

2. The isolated protein of claim 1 , comprising SEQ ID NO:4.

3. The isolated protein of claim 1 , consisting of SEQ ID NO:4.

4. The isolated protein of claim 1 , comprising a substitution of less than 1% of the amino acid sequence set forth as SEQ ID NO:4.

5. A method of stimulating superoxide formation comprising administration in vitro of a composition comprising the isolated protein of claim 1 in a carrier.

6. The method of claim 5 , wherein the protein comprises the amino acid sequence of SEQ ID NO;4.

7. A method of determining the activity of a compound comprising preparing a cell lysate from a host cell expressing the isolated protein of claim 1 ; measuring the ability of the compound to inhibit the enzyme activity of the protein in the lysate wherein a decrease in the generation of superoxide in the lysate as compared to a control indicates that the compound, inhibits the enzymatic activity of the protein.

8. The method of claim 7 , wherein the protein comprises the amino acid sequence of SEQ ID NO:4 or a fragment thereof capable of generating superoxide.

9. An isolated protein, comprising the C-terminal 265 amino acids of SEQ ID NO:4 capable of generating superoxide.

10. The isolated protein of claim 9 , consisting of the C-terminal 265 amino acids of SEQ ID NO:4.

11. The isolated protein of claim 9 , wherein the isolated protein has diaphorase activity.

Assignments (2)
CONFIRMATORY LICENSE Recorded Feb 6, 2013
From: EMORY UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029768/0449 →
CONFIRMATORY LICENSE Recorded Sep 28, 2012
From: EMORY UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029050/0895 →
Continuity (6)
Continuation 0999924800 · Nov 15, 2001
Provisional Application 6024930500 · Nov 16, 2000
Provisional Application 6025136400 · Dec 5, 2000
Provisional Application 6028917200 · May 7, 2001
Provisional Application 6028953700 · May 7, 2001
Related Publication 20040253681A1 · Dec 16, 2004